Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 801

1.

Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study.

Kiladjian JJ, Zachee P, Hino M, Pane F, Masszi T, Harrison CN, Mesa R, Miller CB, Passamonti F, Durrant S, Griesshammer M, Kirito K, Besses C, Moiraghi B, Rumi E, Rosti V, Blau IW, Francillard N, Dong T, Wroclawska M, Vannucchi AM, Verstovsek S.

Lancet Haematol. 2020 Jan 23. pii: S2352-3026(19)30207-8. doi: 10.1016/S2352-3026(19)30207-8. [Epub ahead of print]

PMID:
31982039
2.

Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial.

Kimura S, Imagawa J, Murai K, Hino M, Kitawaki T, Okada M, Tanaka H, Shindo M, Kumagai T, Ikezoe T, Uoshima N, Sato T, Watanabe R, Kowata S, Hayakawa M, Hosoki T, Ikeda K, Kobayashi T, Kakinoki Y, Nishimoto T, Takezako N, Shibayama H, Takaori-Kondo A, Nakamae H, Kawaguchi A, Ureshino H, Sakamoto J, Ishida Y; DADI Trial Group.

Lancet Haematol. 2020 Jan 21. pii: S2352-3026(19)30235-2. doi: 10.1016/S2352-3026(19)30235-2. [Epub ahead of print]

PMID:
31978329
3.

Current status and needs of long-term follow-up clinics for hematopoietic cell transplant survivors: results of a nationwide survey in Japan.

Kurosawa S, Mori A, Tsukagoshi M, Onishi Y, Ohwada C, Mori T, Goto H, Asano-Mori Y, Nawa Y, Hino M, Fukuchi T, Mori Y, Yamahana R, Inamoto Y, Fukuda T.

Biol Blood Marrow Transplant. 2020 Jan 18. pii: S1083-8791(20)30019-7. doi: 10.1016/j.bbmt.2020.01.008. [Epub ahead of print]

PMID:
31962164
4.

Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia.

Imoto W, Yamada K, Yamairi K, Shibata W, Namikawa H, Yukawa S, Yoshii N, Nakaie K, Hirose A, Koh H, Watanabe T, Asai K, Nakamae H, Kaneko Y, Kawaguchi T, Hino M, Kakeya H.

Intern Med. 2020;59(2):193-198. doi: 10.2169/internalmedicine.3358-19. Epub 2020 Jan 15.

5.

Donor KIR2DS1-mediated Decreased Relapse and Improved Survival, Depending on Remission Status at HLA-Haploidentical Transplantation with Post-transplantation Cyclophosphamide.

Ido K, Koh H, Hirose A, Okamura H, Koh S, Nanno S, Nishimoto M, Nakamae M, Nakashima Y, Nakane T, Hino M, Nakamae H.

Biol Blood Marrow Transplant. 2019 Dec 31. pii: S1083-8791(19)31733-1. doi: 10.1016/j.bbmt.2019.12.765. [Epub ahead of print]

PMID:
31899360
6.

Safety profile of the concomitant use of foscarnet and aerosolized pentamidine in allogeneic hematopoietic stem cell transplantation recipients.

Takahashi M, Takahashi K, Inose R, Sugimoto T, Koh H, Hino M, Nagayama K.

Transpl Infect Dis. 2019 Dec 28:e13239. doi: 10.1111/tid.13239. [Epub ahead of print]

PMID:
31883423
7.

Pretransplant serum beta-2 microglobulin level is a potential novel prognostic marker of overall survival after allogeneic hematopoietic cell transplantation - a retrospective observational study.

Harada N, Nakane T, Nakamae M, Hashimoto Y, Okamura H, Nanno S, Nishimoto M, Hirose A, Nakashima Y, Koh H, Hino M, Nakamae H.

Transpl Int. 2019 Dec 13. doi: 10.1111/tri.13564. [Epub ahead of print]

PMID:
31834655
8.

Mosquito allergy: a novel strong prognostic symptom of outcome after allogeneic hematopoietic transplantation.

Koh S, Nakamae H, Nanno S, Nakane T, Nakashima Y, Koh H, Nakamae M, Hirose A, Hino M.

Bone Marrow Transplant. 2019 Dec 5. doi: 10.1038/s41409-019-0759-y. [Epub ahead of print] No abstract available.

PMID:
31804620
9.

Black urine due to cresol intoxication.

Hino M, Kuriyama A, Anzai Y.

Postgrad Med J. 2019 Nov 26. pii: postgradmedj-2019-137286. doi: 10.1136/postgradmedj-2019-137286. [Epub ahead of print] No abstract available.

PMID:
31771965
10.

Elliptic neutron-focusing supermirror for illuminating small samples in neutron reflectometry.

Hosobata T, Yamada NL, Hino M, Yoshinaga H, Nemoto F, Hori K, Kawai T, Yamagata Y, Takeda M, Takeda S.

Opt Express. 2019 Sep 16;27(19):26807-26820. doi: 10.1364/OE.27.026807.

PMID:
31674555
11.

Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia.

Fujishima N, Uchida T, Onishi Y, Jung CW, Goh YT, Ando K, Wang MC, Ono C, Matsumizu M, Paccagnella ML, Sleight B, Vandendries E, Fujii Y, Hino M.

Int J Hematol. 2019 Dec;110(6):709-722. doi: 10.1007/s12185-019-02749-0. Epub 2019 Nov 13.

PMID:
31655984
12.

Combination of Frailty Status and Comorbidity Score Improves the Stratification of Survival in Patients With Myelodysplastic Syndrome Owing to Good Predictive Capability for Infection-related Mortality.

Sakatoku K, Takeoka Y, Miura A, Araki T, Fujitani Y, Yamamura R, Nakamae H, Ohta K, Hino M.

Clin Lymphoma Myeloma Leuk. 2019 Dec;19(12):799-805. doi: 10.1016/j.clml.2019.09.610. Epub 2019 Sep 28.

PMID:
31648956
13.

Managed retreat through voluntary buyouts of flood-prone properties.

Mach KJ, Kraan CM, Hino M, Siders AR, Johnston EM, Field CB.

Sci Adv. 2019 Oct 9;5(10):eaax8995. doi: 10.1126/sciadv.aax8995. eCollection 2019 Oct.

14.

Differential protein expression of DARPP-32 versus Calcineurin in the prefrontal cortex and nucleus accumbens in schizophrenia and bipolar disorder.

Kunii Y, Hino M, Matsumoto J, Nagaoka A, Nawa H, Kakita A, Akatsu H, Hashizume Y, Yabe H.

Sci Rep. 2019 Oct 16;9(1):14877. doi: 10.1038/s41598-019-51456-7.

15.

Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese patients.

Nakane T, Okamura H, Tagaito Y, Koh S, Yoshimura T, Makuuchi Y, Nanno S, Nakamae M, Hirose A, Nakashima Y, Koh H, Hino M, Nakamae H.

Int J Hematol. 2019 Dec;110(6):736-742. doi: 10.1007/s12185-019-02743-6. Epub 2019 Sep 27.

PMID:
31560116
16.

Association Between Vertebral Fracture and Diffuse Idiopathic Skeletal Hyperostosis.

Murakami Y, Mashima N, Morino T, Fukuda T, Iwase M, Hino M, Misaki H, Miura H.

Spine (Phila Pa 1976). 2019 Sep;44(18):E1068-E1074. doi: 10.1097/BRS.0000000000003151.

PMID:
31479433
17.

The case for strategic and managed climate retreat.

Siders AR, Hino M, Mach KJ.

Science. 2019 Aug 23;365(6455):761-763. doi: 10.1126/science.aax8346. No abstract available.

PMID:
31439787
18.

A prospective observational study of immune reconstitution following transplantation with post-transplant reduced-dose cyclophosphamide from HLA-haploidentical donors.

Nakamae H, Fujii K, Nanno S, Okamura H, Nakane T, Koh H, Nakashima Y, Nakamae M, Hirose A, Teshima T, Hino M.

Transpl Int. 2019 Dec;32(12):1322-1332. doi: 10.1111/tri.13494. Epub 2019 Sep 9.

PMID:
31432532
19.

Investigation of betaine as a novel psychotherapeutic for schizophrenia.

Ohnishi T, Balan S, Toyoshima M, Maekawa M, Ohba H, Watanabe A, Iwayama Y, Fujita Y, Tan Y, Hisano Y, Shimamoto-Mitsuyama C, Nozaki Y, Esaki K, Nagaoka A, Matsumoto J, Hino M, Mataga N, Hayashi-Takagi A, Hashimoto K, Kunii Y, Kakita A, Yabe H, Yoshikawa T.

EBioMedicine. 2019 Jul;45:432-446. doi: 10.1016/j.ebiom.2019.05.062. Epub 2019 Jun 26.

20.

Clinical Impacts of Using Serum IL-6 Level as an Indicator of Cytokine Release Syndrome after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.

Nishimoto M, Hirose A, Koh H, Nakamae M, Nanno S, Okamura H, Nakane T, Nakashima Y, Hino M, Nakamae H.

Biol Blood Marrow Transplant. 2019 Oct;25(10):2061-2069. doi: 10.1016/j.bbmt.2019.06.003. Epub 2019 Jun 10.

PMID:
31195139
21.

Expression and Purification of Vaccinia Virus DNA Topoisomerase IB Produced in the Silkworm-Baculovirus Expression System.

Xu J, Lee JM, Tatsuke T, Ebihara T, Masuda A, Hino M, Morokuma D, Fujita R, Mon H, Kusakabe T, Takahashi M.

Mol Biotechnol. 2019 Aug;61(8):622-630. doi: 10.1007/s12033-019-00184-4.

PMID:
31165966
22.

Minimal amount of tissue-based pH measurement to improve quality control in neuropsychiatric post-mortem brain studies.

Ono CT, Yu Z, Kikuchi Y, Kunii Y, Hino M, Matsumoto J, Nagaoka A, Ito J, Iwasaki Y, Hagihara H, Miyakawa T, Yoshida M, Saito Y, Niwa SI, Yabe H, Kakita A, Tomita H.

Psychiatry Clin Neurosci. 2019 Sep;73(9):566-573. doi: 10.1111/pcn.12863. Epub 2019 Jun 17.

PMID:
31102310
23.

A noninvasive diagnostic approach using per-rectal portal scintigraphy for sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation.

Okamura H, Koh H, Takakuwa T, Ido K, Makuuchi Y, Ine S, Nanno S, Nakashima Y, Nakane T, Jogo A, Yamamoto A, Hamuro M, Kotani K, Kawabe J, Higashiyama S, Yoshida A, Shiomi S, Ohsawa M, Hino M, Nakamae H.

Bone Marrow Transplant. 2019 May 14. doi: 10.1038/s41409-019-0537-x. [Epub ahead of print] No abstract available.

PMID:
31089276
24.

ProGRP as early predictive marker of non-small-cell lung cancer to small-cell lung cancer transformation after EGFR-TKI treatment.

Kato Y, Tanaka Y, Hino M, Gemma A.

Respir Med Case Rep. 2019 Apr 13;27:100837. doi: 10.1016/j.rmcr.2019.100837. eCollection 2019.

25.

Chemically defined and growth-factor-free culture system for the expansion and derivation of human pluripotent stem cells.

Yasuda SY, Ikeda T, Shahsavarani H, Yoshida N, Nayer B, Hino M, Vartak-Sharma N, Suemori H, Hasegawa K.

Nat Biomed Eng. 2018 Mar;2(3):173-182. doi: 10.1038/s41551-018-0200-7. Epub 2018 Mar 5.

PMID:
31015717
26.

Identification of sinensetin and nobiletin as major antitrypanosomal factors in a citrus cultivar.

Nakanishi M, Hino M, Yoshimura M, Amakura Y, Nomoto H.

Exp Parasitol. 2019 May;200:24-29. doi: 10.1016/j.exppara.2019.03.008. Epub 2019 Mar 18.

PMID:
30898543
27.

Clinical Value of Fused PET/MRI for Surgical Planning in Patients With Oral/Oropharyngeal Carcinoma.

Hayashi K, Kikuchi M, Imai Y, Yamashita D, Hino M, Ito K, Shimizu K, Harada H, Shinohara S.

Laryngoscope. 2020 Feb;130(2):367-374. doi: 10.1002/lary.27911. Epub 2019 Mar 21.

PMID:
30897225
28.

Short-Term Fasting Induces Cell Cycle Arrest in Immature Hematopoietic Cells and Increases the Number of Naïve T Cells in the Bone Marrow of Mice.

Takakuwa T, Nakashima Y, Koh H, Nakane T, Nakamae H, Hino M.

Acta Haematol. 2019;141(3):189-198. doi: 10.1159/000496096. Epub 2019 Mar 6.

PMID:
30840964
29.

The Proportional Relationship Between Pretransplant WT1 mRNA Levels and Risk of Mortality After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Not in Remission.

Ido K, Nakamae M, Koh H, Okamura H, Nanno S, Nishimoto M, Takeoka Y, Hirose A, Nakashima Y, Hashimoto Y, Nakane T, Hino M, Nakamae H.

Transplantation. 2019 Oct;103(10):2201-2210. doi: 10.1097/TP.0000000000002662.

PMID:
30801534
30.

High-tide flooding disrupts local economic activity.

Hino M, Belanger ST, Field CB, Davies AR, Mach KJ.

Sci Adv. 2019 Feb 15;5(2):eaau2736. doi: 10.1126/sciadv.aau2736. eCollection 2019 Feb.

31.

Calcium Channel Blockers Possibly Delay the Elimination of Plasma Methotrexate in Patients Receiving High-Dose Methotrexate Therapy.

Inose R, Takahashi K, Nanno S, Hino M, Nagayama K.

J Chemother. 2019 Feb;31(1):30-34. doi: 10.1080/1120009X.2018.1544194.

PMID:
30773130
32.

A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency.

Sato Y, Tanaka Y, Hino M, Seike M, Gemma A.

Respir Med Case Rep. 2019 Jan 28;26:223-226. doi: 10.1016/j.rmcr.2019.01.021. eCollection 2019.

33.

[Refractory ascites caused by lymphatic flow disorder after stem cell transplantation for acute myeloid leukemia].

Takakuwa T, Okuno T, Nishimoto M, Nanno S, Takeoka Y, Nakashima Y, Koh H, Nakane T, Wanibuchi H, Hino M, Nakamae H.

Rinsho Ketsueki. 2019;60(1):12-16. doi: 10.11406/rinketsu.60.12. Japanese.

PMID:
30726817
34.

[Successful treatment with rituximab in acute disseminated encephalomyelitis with whole spinal cord involvement following HLA haploidentical transplantation].

Makuuchi Y, Nishimoto M, Yamamoto K, Takahashi T, Kuno M, Nakashima Y, Koh H, Nakane T, Hino M, Nakamae H.

Rinsho Ketsueki. 2018;59(12):2588-2593. doi: 10.11406/rinketsu.59.2588. Japanese.

PMID:
30626794
35.

Pathological alterations of chondroitin sulfate moiety in postmortem hippocampus of patients with schizophrenia.

Yukawa T, Iwakura Y, Takei N, Saito M, Watanabe Y, Toyooka K, Igarashi M, Niizato K, Oshima K, Kunii Y, Yabe H, Matsumoto J, Wada A, Hino M, Iritani S, Niwa SI, Takeuchi R, Takahashi H, Kakita A, Someya T, Nawa H.

Psychiatry Res. 2018 Dec;270:940-946. doi: 10.1016/j.psychres.2018.10.062. Epub 2018 Oct 30.

PMID:
30551347
36.

Successful treatment of invasive pulmonary aspergillosis caused by Aspergillus felis, a cryptic species within the Aspergillus section Fumigati: A case report.

Yamairi K, Ido K, Nakamura S, Niki M, Imoto W, Shibata W, Namikawa H, Fujimoto H, Yamada K, Nakamae H, Hino M, Kaneko Y, Miyazaki Y, Kakeya H.

J Infect Chemother. 2019 Apr;25(4):307-310. doi: 10.1016/j.jiac.2018.10.016. Epub 2018 Nov 30.

PMID:
30503017
37.

Expression, Purification, and Characterization of Recombinant Human α1-Antitrypsin Produced Using Silkworm-Baculovirus Expression System.

Morifuji Y, Xu J, Karasaki N, Iiyama K, Morokuma D, Hino M, Masuda A, Yano T, Mon H, Kusakabe T, Lee JM.

Mol Biotechnol. 2018 Dec;60(12):924-934. doi: 10.1007/s12033-018-0127-y.

PMID:
30302632
38.

A functional polypeptide N-acetylgalactosaminyltransferase (PGANT) initiates O-glycosylation in cultured silkworm BmN4 cells.

Xu J, Morio A, Morokuma D, Nagata Y, Hino M, Masuda A, Li Z, Mon H, Kusakabe T, Lee JM.

Appl Microbiol Biotechnol. 2018 Oct;102(20):8783-8797. doi: 10.1007/s00253-018-9309-6. Epub 2018 Aug 22.

PMID:
30136207
39.

Risk Factors for Delirium after Spine Surgery: An Age-Matched Analysis.

Morino T, Hino M, Yamaoka S, Misaki H, Ogata T, Imai H, Miura H.

Asian Spine J. 2018 Aug;12(4):703-709. doi: 10.31616/asj.2018.12.4.703. Epub 2018 Jul 27.

40.

Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry.

Nakaya A, Yagi H, Kaneko H, Kosugi S, Kida T, Adachi Y, Shibayama H, Kohara T, Kamitsuji Y, Fuchida SI, Uoshima N, Kawata E, Uchiyama H, Shimura Y, Takahashi T, Urase F, Ohta K, Hamada T, Miyamoto K, Kobayashi M, Shindo M, Tanaka H, Shimazaki C, Hino M, Kuroda J, Kanakura Y, Takaoari-Kondo A, Nomura S, Matsumura I; Kansai Myeloma Forum Investigators.

Leuk Res Rep. 2018 Jul 4;10:7-10. doi: 10.1016/j.lrr.2018.07.001. eCollection 2018.

41.

Validation of previous prognostic models for thrombosis and exploration of modified models in patients with essential thrombocythemia.

Hashimoto Y, Nakamae H, Tanaka T, Omura H, Horiuchi M, Yoshimura T, Takakuwa T, Mugitani A, Hirose A, Nakamae M, Koh H, Hino M.

Eur J Haematol. 2018 Oct;101(4):508-513. doi: 10.1111/ejh.13136. Epub 2018 Aug 31.

PMID:
29971894
42.

COMT Val 108/158 Met polymorphism and treatment response to aripiprazole in patients with acute schizophrenia.

Kaneko H, Miura I, Kanno-Nozaki K, Horikoshi S, Hino M, Yabe H.

Neuropsychiatr Dis Treat. 2018 Jun 22;14:1657-1663. doi: 10.2147/NDT.S164647. eCollection 2018.

43.

Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae.

Masuda A, Lee JM, Miyata T, Sato T, Hayashi S, Hino M, Morokuma D, Karasaki N, Mon H, Kusakabe T.

J Gen Virol. 2018 Jul;99(7):917-926. doi: 10.1099/jgv.0.001087.

PMID:
29851377
44.

Influences of the T102C polymorphism in the 5-HT2A receptor gene on the five-factor model of Positive and Negative Syndrome Scale and treatment response to aripiprazole in patients with acute schizophrenia.

Kanno-Nozaki K, Miura I, Kaneko H, Horikoshi S, Ota T, Nozaki M, Ejiri H, Yahiro M, Watanabe K, Hino M, Yabe H.

Psychiatry Res. 2018 Jul;265:244-245. doi: 10.1016/j.psychres.2018.05.020. Epub 2018 May 8. No abstract available.

PMID:
29763842
45.

Effects of the -141C insertion/deletion polymorphism in the dopamine D2 receptor gene on the dopamine system in the striatum in patients with schizophrenia.

Matsumoto J, Nagaoka A, Kunii Y, Miura I, Hino M, Niwa SI, Nawa H, Takahashi H, Kakita A, Yabe H.

Psychiatry Res. 2018 Jun;264:116-118. doi: 10.1016/j.psychres.2018.03.029. Epub 2018 Mar 29.

PMID:
29627696
46.

Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment.

Okada M, Imagawa J, Tanaka H, Nakamae H, Hino M, Murai K, Ishida Y, Kumagai T, Sato S, Ohashi K, Sakamaki H, Wakita H, Uoshima N, Nakagawa Y, Minami Y, Ogasawara M, Takeoka T, Akasaka H, Utsumi T, Uike N, Sato T, Ando S, Usuki K, Mizuta S, Hashino S, Nomura T, Shikami M, Fukutani H, Ohe Y, Kosugi H, Shibayama H, Maeda Y, Fukushima T, Yamazaki H, Tsubaki K, Kukita T, Adachi Y, Nataduka T, Sakoda H, Yokoyama H, Okamoto T, Shirasugi Y, Onishi Y, Nohgawa M, Yoshihara S, Morita S, Sakamoto J, Kimura S; DADI Trial Group, Japan.

Clin Lymphoma Myeloma Leuk. 2018 May;18(5):353-360.e1. doi: 10.1016/j.clml.2018.03.004. Epub 2018 Mar 15.

47.

DNA methylation of ANKK1 and response to aripiprazole in patients with acute schizophrenia: A preliminary study.

Miura I, Kunii Y, Hino M, Hoshino H, Matsumoto J, Kanno-Nozaki K, Horikoshi S, Kaneko H, Bundo M, Iwamoto K, Yabe H.

J Psychiatr Res. 2018 May;100:84-87. doi: 10.1016/j.jpsychires.2018.02.018. Epub 2018 Feb 23.

PMID:
29499474
48.

Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum.

Matsumura-Kimoto Y, Kuroda J, Kaneko H, Kamitsuji Y, Fuchida SI, Nakaya A, Shibayama H, Uoshima N, Yokota I, Uchiyama H, Yagi H, Kosugi S, Matsui T, Ishikawa J, Matsuda M, Ohta K, Iida M, Tanaka H, Kobayashi M, Wada K, Shimazaki C, Nomura S, Imada K, Hino M, Matsumura I, Kanakura Y, Takaori-Kondo A; Kansai Myeloma Forum Investigators.

Int J Hematol. 2018 May;107(5):541-550. doi: 10.1007/s12185-018-2416-4. Epub 2018 Jan 29.

PMID:
29380179
49.

Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial).

Ishikawa J, Matsumura I, Kawaguchi T, Kuroda J, Nakamae H, Miyamoto T, Matsuoka KI, Shibayama H, Hino M, Hirase C, Kamimura T, Shimose T, Akashi K, Kanakura Y.

Int J Hematol. 2018 May;107(5):535-540. doi: 10.1007/s12185-018-2401-y. Epub 2018 Jan 23.

PMID:
29362980
50.

Outcome of Low-Invasive Local Split-Thickness Lengthening for Iliotibial Band Friction Syndrome.

Inoue H, Hara K, Arai Y, Nakagawa S, Kan H, Hino M, Fujiwara H, Kubo T.

Int J Sports Med. 2018 Feb;39(3):232-236. doi: 10.1055/s-0043-122152. Epub 2018 Jan 23.

PMID:
29361639

Supplemental Content

Support Center